News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Cigna Group stock has delivered a 47.1% total return over the past 5 years, yet current valuation checks still lean toward the shares looking inexpensive rather than fully priced in. In light of recent earnings news and a steady long term track record, investors are weighing whether the recent price of US$282.49 already reflects this progress. Over 5 years, a 47.1% return suggests Cigna Group has rewarded patient shareholders while still inviting a closer look at whether the current price...
The Cigna Group (NYSE:CI) is included among the 10 Best Long-Term Dividend Stocks to Invest In According to Billionaires. On May 26, Barclays turned more cautious on The Cigna Group (NYSE:CI), downgrading the stock to Equal Weight from Overweight. It also trimmed its price target on the stock to $304 from $310.The firm said Cigna […]
With an annual dividend yield of 2.19%, The Cigna Group (NYSE:CI) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds. The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare. On May 20, […]
With an upside potential of 20.18% as of May 3, The Cigna Group (NYSE:CI) is included among the 10 Best Fortune 500 Stocks to Buy According to Analysts. The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare. […]